REGISTERED NUMBER: 11224089 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2025

for

LONDON GI AND LIVER HEALTH LTD

Page

Balance Sheet

1

FIXED ASSETS

88,398

93,837

CURRENT ASSETS

899,501

591,314

CREDITORS

Amounts falling due within one year

(140,095

)

(77,932

)

NET CURRENT ASSETS

759,406

513,382

TOTAL ASSETS LESS CURRENT LIABILITIES

847,804

607,219

CREDITORS

Amounts falling due after more than one year

(18,333

)

(28,333

)

NET ASSETS

829,471

578,886

CAPITAL AND RESERVES

829,471

578,886

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

London Gi And Liver Health Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

11224089

Registered office:

2 St Marys Road

Tonbridge

Kent

TN9 2LB

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2024 - 1 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 14 January 2026 and were signed by:

Dr C A Wadsworth - Director